Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma
Study: Fewer children with asthma who used nebulized ICS early were hospitalized
April 28th, 2005
A new study, presented at the 61st annual American Academy of Allergy, Asthma and Immunology (AAAAI) showed that children who were prescribed a nebulized inhaled corticosteroid (ICS) as first-line treatment for asthma experienced fewer emergency department (ED) visits or hospitalizations than children prescribed the medication as second or third-line treatment. Asthma is the most common chronic medical condition among children under the age of 15 and the third leading cause of hospitalization in that age group. In the study, 25% of children who received nebulized ICS as an initial therapy had to visit an ED or stay in the hospital at least once...
Source: Women's Health Weekly (2005-04-28)
|
